This is unpublished

Demetrio
Sharp Dimitri
MD, MSc

Demetrio Sharp Dimitri portrait
Fellow
Pinned
Academic
Fellow, General Cardiology, Year 2

background

From the Dominican Republic, I am Demetrio Sharp Dimitri, MD, MSc, deeply committed to the advancement of cardiology through innovative treatments for heart disease. My journey has led me to the University of Cincinnati, where I completed Internal Medicine together with an NIH-funded R-38 research year, and now to UW for a Cardiology Fellowship, where I am devoted to learning, patient care, and contributing to the field, with a focus on advanced heart failure, cardiovascular critical care, interventional cardiology, and electrophysiology. Outside the hospital, my life is full of vitality, from Orange Theory workouts and running to enjoying golf, soccer, outdoor adventures, and the pleasures of wine and culinary explorations.

medical school

Universidad Iberoamericana (UNIBE) School of Medicine

residency

University of Cincinnati

recent publications and presentations

Subramaniam, A., Sharp Dimitri, D., Mackensen, G.B., Elison, D., Chung, C.J., & McCabe, J.M. (2025). Novel Use of MitraClip for Treatment of Severe Aortic Regurgitation. Journal of the Society for Cardiovascular Angiography & Interventions. DOI: 10.1016/j.jscai.2025.102583.

Sharp Dimitri, D., Pourriahi, M., Zhou, C., Jandarov, R., Kay, D., Jose, A., Cook, J., Elwing, J., & Gomez-Arroyo, J. (2024). Mortality Risk Assessment Using the REVEAL 2.0 Score in Pulmonary Hypertension Secondary to Left Heart Disease. Research Square (Preprint). DOI: 10.21203/rs.3.rs-4474171/v1.

Ariss, R., Sharp Dimitri, D., Cook, J.L., & Pourriahi, M. (2023, Mar). SGLT-2 Inhibitors Are Efficacious In High-Risk Subgroups Of Patients With Heart Failure With Mildly Reduced Or Preserved Ejection Fraction. Journal of the American College of Cardiology, 81(8_Supplement), 277. Pub Status: Published. Article URL: https://doi.org/10.1016/S0735-1097(23)0…

Robert, A., Sharp Dimitri, D., Levy, W.C., & Pourriahi, M. (2023, Mar). Robustness Of Outcomes In SGLT-2 Inhibitor Trials In Patients With Heart Failure With Mildly Reduced Or Preserved Ejection Fraction. Journal of the American College of Cardiology, 81(8_Supplement), 758. Pub Status: Published. Article URL: https://doi.org/10.1016/S0735-1097(23)0…

Sharp Dimitri, D., Albertus, P., Khan, M., Panakos, A., Alfonso, C. E., & Orozco-Sevilla, V. (2023, May). Asymptomatic Anomalous Left Coronary Artery from the Pulmonary Artery (ALCAPA) in an Adult. Journal of Surgery and Research, 6(2023), 215-216. Pub Status: Published. Article URL: https://fortuneonline.org/articles/asymptomatic- anomalous-left-coronary-artery-from-the-pulmonary-artery-alcapa-in-an-adult.html

Sharp Dimitri, D., Zhou, C., Mai, E., Pourriahi, M., Cook, J. L., Elwing, J. M., & Gomez- Arroyo, J. (2023, August 26). REVEAL Score Performance in Patients with Group 2 Pulmonary Hypertension. [Poster presented]. European Society of Cardiology 2023/Amsterdam, NLD.

Sharp Dimitri, D., Robert, A., Levy, W.C., & Pourriahi, M. (2023, March 06). Robustness Of Outcomes In SGLT-2 Inhibitor Trials In Patients With Heart Failure With Mildly Reduced Or Preserved Ejection Fraction. [Poster presented]. ACC 23/New Orleans, LA, USA.

CONTACTS

Mailing Address:
University of Washington Medical Center,
1959 NE Pacific Street,
Box 356422,
Seattle, WA 98195-6422

Clinical Contacts:
For appointments or other clinical matters, please contact the Heart Institute.